NEW DELHI : Amidst race for covid-19 vaccine among pharmaceutical companies, close to two third of the clinical trials in India are being done on traditional medicines, like ayurveda and homeopathy – under the AYUSH system-- with highest public and private funding.As of July, a total of 203 trials were registered in the Clinical Trial Registry of India (CTRI), of which 125 trials (61.5%) were related to the AYUSH interventions, while 64 trials (30.7%) were on allopathic drugs, reveals an analysis done by the All India Institute of Medical Sciences (AIIMS), Jodhpur.The analysis showed that just 12 trials related to the Chloroquine and Hydroxychloroquine as monotherapy or with other drugs were registered on CTRI.